Journal
INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 2, Issue 8, Pages 1183-1193Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/S1567-5769(02)00086-3
Keywords
influenza vaccine; mucosal immunity; oral adjuvant; pinellic acid; Pinellia ternata
Categories
Ask authors/readers for more resources
This study describes the isolation, purification, characterization, and adjuvant activity of an orally active adjuvant substance from the tuber of Pinellia ternata, as an active herbal component of the traditional Japanese herbal (Kampo) medicine, Shoseiryu-to (SST, Chinese name: Xiao-Qing-Long-Tang), which has been reported to show oral adjuvant activity for nasally administered influenza RA vaccine [Int. J. Immunopharmacol. 16 (1994) 605]. The active compound was identified as 9S, 12S, 13S-trihydroxy-10E-octadecenoic acid using infrared spectra, proton magnetic resonance, mass spectrometry, and circular dichroism, and named pinellic acid. Oral administration of pinellic acid (1 mug) to BALB/c mice given primary and secondary intranasal inoculations of influenza HA vaccine (1 mug) enhanced antiviral IgA antibody (Ab) titers 5.2- and 2.5-fold in nasal and bronchoalveolar washes, respectively, and antiviral IgG Ab titers Mold in bronchoalveolar wash and serum. Intranasal administration of pinellic acid (1 mug) with influenza HA vaccine (1 mug) slightly enhanced antiviral IgG Ab titers in bronchoalveolar wash and serum but not antiviral IgA Ab titers in nasal and bronchoalveolar washes. Pinellic acid showed no hemolytic activity. The results of this study suggest that pinellic acid may provide a safe and potent oral adjuvant for nasal influenza HA vaccine. (C) 2002 Elsevier Science B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available